|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6750 GBX | 0.00% |
|
0.00% | +28.57% |
| Market Cap | 5.62M 7.56M 6.56M 6.14M 10.61M 720M 10.74M 71.85M 28.2M 360M 28.38M 27.76M 1.2B | P/E 2024 |
-1.69x | P/E 2025 | -3.09x |
|---|---|---|---|---|---|
| Enterprise Value | 4.54M 6.11M 5.3M 4.96M 8.57M 582M 8.68M 58.04M 22.78M 291M 22.92M 22.43M 967M | EV / Sales 2024 |
198,657,512x | EV / Sales 2025 | 452,941,079x |
| Free-Float |
41.35% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Thalia Therapeutics Plc
| 1 month | +3.85% | ||
| 3 months | +17.39% | ||
| 6 months | +42.11% | ||
| Current year | +28.57% |
| 1 week | 0.65 |  | 0.7 |
| 1 month | 0.6 | | 0.75 |
| Current year | 0.4 | | 0.95 |
| 1 year | 0.4 | | 1 |
| 3 years | 0.35 | | 1.7 |
| 5 years | 0.35 | | 10.12 |
| 10 years | 0.35 | | 35.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Solomon
CEO | Chief Executive Officer | 66 | 24/02/2026 |
Rachel Schiller
COO | Chief Operating Officer | - | - |
Fiona McLaughlin
CTO | Chief Tech/Sci/R&D Officer | 56 | 27/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Cairns
BRD | Director/Board Member | 48 | 14/07/2020 |
| Chairman | 59 | 01/08/2023 | |
| Director/Board Member | 81 | 09/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/28/24 A | Free | Founder | 6,000,000 | 1.5198% | ||
| 11/28/24 A | Free | Director | 3,000,000 | 0.7599% | ||
| 11/28/24 A | Free | Chairman | 3,000,000 | 0.7599% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +50.00% | -57.81% | 7.56M | |
| -3.25% | +13.72% | +52.49% | +88.86% | 62.92B | |
| +2.68% | +3.92% | +34.46% | +75.12% | 54.32B | |
| -1.07% | -1.79% | -18.07% | -14.36% | 22.91B | |
| +33.86% | +30.60% | +19.14% | +502.77% | 28.73B | |
| +10.83% | +18.38% | +52.76% | +4.58% | 21.65B | |
| +9.40% | +10.36% | +41.79% | -19.28% | 17.76B | |
| -3.37% | +25.85% | +213.21% | +369.13% | 16.47B | |
| +6.20% | +11.51% | +34.94% | +681.88% | 15.48B | |
| -7.94% | -6.74% | +38.42% | +157.52% | 13.12B | |
| Average | +4.74% | +7.27% | +51.91% | +178.84% | 25.34B | |
| Weighted average by Cap. | +4.85% | +8.61% | +46.38% | +166.73% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.01 0.01 0.01 0.01 0.01 0.93 0.01 0.09 0.04 0.47 0.04 0.04 1.55 | 0.01 0.01 0.01 0.01 0.01 0.93 0.01 0.09 0.04 0.47 0.04 0.04 1.55 |
| Net income | -1.06M -1.42M -1.24M -1.16M -2M -136M -2.02M -13.54M -5.31M -67.78M -5.35M -5.23M -226M | -1.21M -1.62M -1.41M -1.32M -2.27M -154M -2.3M -15.41M -6.05M -77.16M -6.09M -5.95M -257M |
| Net Debt | -626K -842K -731K -684K -1.18M -80.22M -1.2M -8.01M -3.14M -40.08M -3.16M -3.09M -133M | -1.08M -1.45M -1.26M -1.18M -2.04M -138M -2.06M -13.8M -5.42M -69.11M -5.45M -5.33M -230M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | GBX 0.6750 | 0.00% | 189,301 |
| 06/08/26 | GBX 0.6750 | 0.00% | 81,802 |
| 05/08/26 | GBX 0.6750 | 0.00% | 74,667 |
| 04/08/26 | GBX 0.6750 | 0.00% | 202,941 |
| 03/08/26 | GBX 0.6750 | 0.00% | 238,579 |
- Stock Market
- Stocks
- THAT Stock
Select your edition
All financial news and data tailored to specific country editions
